Sindell v. Abbott Laboratories (1980)
نویسنده
چکیده
Sindell v. Abbott Laboratories was a 1980 California case that established the doctrine of market share liability for personal injury cases. For such liability, when a drug causes personal injury and the manufacturer of the drug cannot be identified, each producer is responsible for paying the settlement in proportion to the percentage of the market they supplied. Judith Sindell and Maureen Rogers brought the case against the producers of diethylstilbestrol (DES), which their mothers had taken during pregnancy [4] to prevent miscarriage [5] and other complications. Sindell and Rogers alleged that their mothers' ingestions of DES during pregnancy [4] later caused Sindell and Rogers to develop cancers at the onset of puberty, but they could not identify the specific manufacturer of the drug. The market share liability ruling in Sindell allowed millions of DES-affected individuals to seek restitution for reproductive cancers caused by prenatal exposure to DES.
منابع مشابه
Market Share Liability Adopted to Overcome Defendant Identification Requirement in DES Litigation, Sindell v. Abbott Laboratories, 26 Cal. 3d 588, 607 P.2d 924, 163 Cal. Rptr. 132, cert. denied, 101 S. Ct. 286 (1980)
متن کامل
Wrongful life: impaired infant's cause of action recognized--Curlender v. Bio-Science Laboratories.
متن کامل
Analysis of the November 3, Performance Evaluation Testing Results for Human T-lymphotropic Virus Types I and II Antibody
This report is an analysis of results provided to the Centers for Disease Control and Prevention (CDC) by participant laboratories in the Model Performance Evaluation Program (MPEP) after they tested the human T-lymphotropic virus types I and II (HTLV-I/II) performance evaluation samples shipped to them on November 3, 1997. Testing results for this analysis were provided by 185 (96.9%) of 191 l...
متن کاملReview of Batch-to-batch Variation of PeliSpy Type 7, a Multimarker Quality Control Sample Used to Monitor the Performance of Abbott PRISM Chemiluminescent Immunoassays
The National Serology Reference Laboratory, Australia (NRL) has conducted a quality control (QC) programme for laboratories using the Abbott PRISM chemiluminescent immunoassays (PRISM; Abbott Laboratories, Wiesbaden, Germany) using an Internet-based QC monitoring program, EDCNet (https://www.nrlqa.net) since 2001. Participating blood screening laboratories tested aliquots of a low positive mult...
متن کاملCoprevalence of autoantibodies to cardiac troponin I and T in normal blood donors.
Employment or Leadership: N.G. Morgenthaler, BRAHMS; A. Bergmann, BRAHMS. Consultant or Advisory Role: M.H. Brutsche, advisory boards for Pfizer (Champix, Spiriva), GlaxoSmithKline, and Novartis; C. Mueller, BRAHMS and Abbott Laboratories. Stock Ownership: A. Bergmann, BRAHMS. Honoraria: C. Mueller, Biosite, Abbott Laboratories, Roche, BRAHMS, and Siemens. Research Funding: M.T. Maeder, Swiss S...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2018